Clinical Trials Logo

Refractive Errors clinical trials

View clinical trials related to Refractive Errors.

Filter by:

NCT ID: NCT03334513 Completed - Clinical trials for Retinopathy of Prematurity

Refractive Error and Biometry in Retinopathy of Prematurity

Start date: April 1, 2011
Phase: N/A
Study type: Observational

The investigators compared long-term refractive and biometric outcomes in children with retinopathy of prematurity who received two different anti-vascular endothelial growth factor agents.

NCT ID: NCT03319212 Completed - Ametropia Clinical Trials

Clinical Characterization of Symptomatic Populations

Start date: September 29, 2017
Phase: N/A
Study type: Interventional

This is an unmasked, non-randomized, single arm, stratified, dispensing investigation of symptomatic and asymptomatic subject populations. Subjects will be assigned to a single study lens type to be worn bilaterally for approximately 4 weeks followed by no contact lens wear for 1 week.

NCT ID: NCT03312257 Completed - Refractive Errors Clinical Trials

Bifocal & Atropine in Myopia (BAM) Study

BAM
Start date: July 2016
Phase: N/A
Study type: Interventional

This study will test whether the combined treatment of 0.01% atropine and soft bifocal contact lens wear produces slower myopia progression and axial elongation compared to soft bifocal contact lenses alone in children ages 7 to 11 years old.

NCT ID: NCT03305770 Completed - Myopia Clinical Trials

DD T2 Daily Disposable Registration Trial

Start date: October 12, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the performance of the investigational verofilcon A contact lens compared to the commercially available delefilcon A contact lens, by assessing visual acuity as the primary variable.

NCT ID: NCT03292614 Completed - Refractive Errors Clinical Trials

Measurement of Refractive SE Following Implantation of LS313 MF30 IOL

Start date: June 1, 2017
Phase:
Study type: Observational

This Study determines the most precise method for measuring post-operative refraction following implantation of the asymmetric multifocal LS-313 MF30 comparing the results of Refraction of the different Autorefractor Keratometers with the subjective measurements for distance and near.

NCT ID: NCT03278587 Completed - Cataract Clinical Trials

Village-Integrated Eye Worker Trial II - Pilot

VIEW II Pilot
Start date: May 31, 2018
Phase: N/A
Study type: Interventional

The vast majority of blindness is avoidable. The World Health Organization (WHO) estimates that 80% of cases of visual impairment could be prevented or reversed with early diagnosis and treatment. The leading causes of visual impairment are cataract and refractive error, followed by glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). Loss of vision from these conditions is not inevitable; however, identifying at-risk cases and linking cases with appropriate care remain significant challenges. Worldwide, eye health care systems must determine optimal strategies for reaching people outside of their immediate orbit in order to reduce visual impairment. Visual impairment can be reduced by case detection of prevalent disease like cataract and refractive error, or by screening for early disease like glaucoma, AMD, and DR and preventing progression. Systems around the world have developed numerous approaches to both case detection and screening but there is very little research to support the choice of allocating resources to case detection or screening and little data exists on the cost effectiveness of the various approaches to each. VIEW II Pilot is a cluster-randomized trial to determine the effectiveness of different approaches to community-based case detection and screening for ocular disease. Communities in Nepal will be randomized to one of four arms: 1) a comprehensive ocular screening program, 2) a cataract camp-based program, 3) a community health worker-based program, and 4) no program.

NCT ID: NCT03169153 Completed - Refractive Error Clinical Trials

Clinical Comparison of Silicone Hydrogel Monthly Lenses

Start date: September 22, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to compare AIR OPTIX® plus HydraGlyde (AOHG) contact lenses to ACUVUE® VITA® (VITA) contact lenses for total lipid uptake (total of surface and bulk uptake) after 30 days of wear by high lipid depositors.

NCT ID: NCT03118934 Completed - Presbyopia Clinical Trials

Assessing Fitting Guides in Alcon Multifocal Contact Lenses

Start date: May 17, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to compare an alternative fitting guide to a current fitting guide for optimizing contact lens parameters and determining contact lens prescription.

NCT ID: NCT03095027 Completed - Refractive Error Clinical Trials

Clinical Performance of a Silicone Hydrogel for Daily Disposable Wear

Start date: April 19, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the visual acuity of an investigational silicone hydrogel to a commercially available silicone hydrogel in contact lens wearers.

NCT ID: NCT03034928 Completed - Refractive Errors Clinical Trials

Clinical Biocompatibility Evaluation of Contact Lens Coatings

Start date: February 14, 2017
Phase: N/A
Study type: Interventional

The primary objective is to evaluate corneal staining observed after 2 hours of wear with contact lenses with investigational coating against PureVision™ lenses, all pre-cycled with OPTI-FREE® RepleniSH® multi-purpose disinfection solution.